1 Biotech Stock That Could Have Investors Looking At A Billion-Dollar Opportunity

0
5965

The recent $12 billion acquisition of Kite Pharma, Inc. by big-pharma giant, Gilead Sciences has biotech investors hungry for the next big buyout target. This has begged the question, “Does this one biotech stock have what it takes to be a billion dollar opportunity?”

CLICK HERE TO ACCESS THIS FULL REPORT

LEAVE A REPLY

Please enter your name here
Please enter your comment!